Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | GSTP1 | P09211 | 12/20 | 0.42 |
| ▸ | GSTM2 | P28161 | 11/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | MYC | P01106 | 2/20 | 0.39 |
| ▸ | MAX | P61244 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | S100A4 | P26447 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6259333 | 0.80 | MEN1 (0.54) | MEN1KMT2AGSTP1GSTM2 | |
| SCHEMBL7830878 | 0.77 | GSTM2 (0.61) | MEN1KMT2AGSTM2MYCMAX | |
| SCHEMBL4439764 | 0.75 | MEN1 (0.54) | MEN1KMT2AGSTP1GSTM2USP2 | |
| SCHEMBL7714790 | 0.72 | GSTP1 (0.54) | MEN1KMT2AGSTP1GSTM2MYC | |
| SCHEMBL3505281 | 0.70 | MEN1 (0.59) | MEN1KMT2AGSTP1GSTM2MYC | |
| SCHEMBL15515612 | 0.69 | GSTM2 (0.76) | MEN1KMT2AGSTM2MYCMAX | |
| SCHEMBL15516469 | 0.69 | GSTM2 (0.76) | MEN1KMT2AGSTM2MYCMAX | |
| SCHEMBL1076589 | 0.68 | MEN1 (0.60) | MEN1KMT2AGSTP1GSTM2MYC | |
| SCHEMBL6385100 | 0.68 | GSTM2 (0.52) | MEN1KMT2AGSTP1GSTM2MYC | |
| Dodecanoate SCHEMBL27633294 | 0.68 | PPARG (0.55) | MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3452441-B1 | ALPHA-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | UNIV NEW YORK STATE RES FOUND (US) | 2025-08-27 | — | — | EP | disclosed |
| US-20240384208-A1 | CLEANSING COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-11-21 | — | — | US | disclosed |
| EP-4408964-A1 | CLEANSING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-08-07 | — | — | EP | disclosed |
| CN-118076721-A | Cleaning composition | 联合利华知识产权控股有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20240092725-A1 | ALPHA-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-03-21 | — | — | US | disclosed |
| US-20230365488-A1 | TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-11-16 | — | — | US | disclosed |
| CN-117015371-A | Sanitary cleaning composition for female private parts | 联合利华知识产权控股有限公司 | 2023-11-07 | — | — | CN | disclosed |
| US-11739047-B2 | Alpha-truxillic acid derivatives and pharmaceutical compositions thereof | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-08-29 | — | — | US | disclosed |
| CN-116615193-A | Tumoxic acid monoester derivative as selective FABP5 inhibitor, pharmaceutical composition and application thereof | 纽约州立大学研究基金会 | 2023-08-18 | — | — | CN | disclosed |
| EP-4225292-A1 | TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | The Research Foundation for The State University of New York (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023052124-A1 | CLEANSING COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-04-06 | — | — | WO | disclosed |
| US-20230025694-A1 | Silicone Hydrogel Based Fluorescent Assay and Contact Lens | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-01-26 | — | — | US | disclosed |
| US-11369295-B2 | Silicone hydrogel based fluorescent assay and contact lens | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2022-06-28 | — | — | US | disclosed |
| CN-109415295-B | Alpha-cocatalytic derivatives and pharmaceutical compositions thereof | 纽约州立大学研究基金会 | 2022-05-17 | — | — | CN | disclosed |
| WO-2022076820-A1 | TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2022-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092725-A1 | ALPHA-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | FABP1, FABP2, FABP4 | MEN1 4882/4885KMT2A 4597/4885GSTP1 2184/4885 |
| US-20230025694-A1 | Silicone Hydrogel Based Fluorescent Assay and Contact Lens | CD44, CRYAA, IGFBP1 | MEN1 901/4885KMT2A 4319/4885GSTP1 2365/4885 |
| US-11739047-B2 | Alpha-truxillic acid derivatives and pharmaceutical compositions thereof | FABP1, FABP2, FABP4 | MEN1 4880/4885KMT2A 4609/4885GSTP1 2197/4885 |
| US-11369295-B2 | Silicone hydrogel based fluorescent assay and contact lens | CD44, CRYAA, IGFBP1 | MEN1 901/4885KMT2A 4319/4885GSTP1 2365/4885 |
| US-20230365488-A1 | TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | FABP5, FABP1, FABP4 | MEN1 4822/4885KMT2A 4141/4885GSTP1 2599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.